Karen L. Tubridy

Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates

David A. Roth, Craig M. Kessler, John Pasi et al. · Blood · 2001 · 185 citations · Full text

Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients

Amy D. Shapiro, Margaret V. Ragni, Leonard A. Valentino et al. · Blood · 2011 · 169 citations · Full text

Clinical evaluation of recombinant factor IX.

G. White, Amy D. Shapiro, Margaret V. Ragni et al. · PubMed · 1998 · 107 citations

Use of recombinant factor IX in subjects with haemophilia B undergoing surgery

Margaret V. Ragni, John Pasi, G C White et al. · Haemophilia · 2002 · 62 citations

A Phase 2 Exploratory Study of a Novel Interleukin-1 Receptor Inhibitor (EBI-005) in the Treatment of Moderate-to-Severe Allergic Conjunctivitis

Michael H. Goldstein, Karen L. Tubridy, Jennifer Agahigian et al. · Eye & Contact Lens Science & Clinical Practice · 2015 · 20 citations